Select Medical Holdings Corporation
SEM · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.87 | 0.12 | -0.18 | 0.09 |
| FCF Yield | 22.16% | 22.64% | 5.67% | 10.70% |
| EV / EBITDA | 9.96 | 8.15 | 11.44 | 8.68 |
| Quality | ||||
| ROIC | 0.05% | 6.41% | 4.49% | 8.89% |
| Gross Margin | 12.22% | 13.99% | 11.58% | 14.82% |
| Cash Conversion Ratio | 1.75 | 1.94 | 1.44 | 0.80 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.44% | 2.41% | 4.62% | 4.39% |
| Free Cash Flow Growth | 52.94% | 273.58% | -57.20% | -74.97% |
| Safety | ||||
| Net Debt / EBITDA | 5.18 | 6.17 | 8.59 | 6.01 |
| Interest Coverage | 0.03 | 2.79 | 2.38 | 5.25 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -74.81 | 0.00 |
| Cash Conversion Cycle | 46.40 | 40.40 | 37.20 | 36.17 |